Cytokine inhibitor monotherapies can ameliorate depression (Kappelmann et al., 2018; Köhler et al., 2019) and antidepressant treatment also significantly decreases peripheral levels of IL‐6, TNF, and IL‐10 (Köhler et al., 2018). Here, IL6 is linked to depressive disorder.